Brukinsa (zanubrutinib)

pCPA File Number: 21683

Negotiation Status:

Concluded with an LOI

Indication(s):

Waldenström's Macroglobulinemia

Sponsor/Manufacturer:

BeiGene, Ltd.

CDA-AMC Project Number:

PC0248-000

pCPA Engagement Letter Issued:

2022-10-05

Negotiation Process Concluded:

2022-12-22